<DOC>
	<DOCNO>NCT02087683</DOCNO>
	<brief_summary>The purpose study determine effect vitamin D supplementation patient heart failure vitamin D deficiency ventricular function , inflammatory cytokine , brain natriuretic peptide , lipid profile , glucose , serum insulin , serum parathyroid hormone calcium .</brief_summary>
	<brief_title>Effect Vitamin D Supplementation Patients With Heart Failure Vitamin D Deficiency</brief_title>
	<detailed_description>The protocol hold three different Hospitals Monterrey . Those patient heart failure invite participate ; serum vitamin D measure , vitamin D deficiency participate , meet inclusion criterion none exclusion criterion , sign inform consent . Patients assigned intervention group placebo group accord characteristic group equally balance proportion similar characteristic number guarantee homogeneity group baseline . The study 12-month time frame patient . Patients enrol different time . All patient undergo : - A baseline measurement vitamin D concentration plasma every three month ( accord season change ) total five measurement . - Myocardial function structure measure magnetic resonance contrast medium baseline end intervention . - Heart failure clinical follow-up 6 minute walk test , arterial pressure clinical parameter every month . - A baseline measurement serum BNP every three month ( 5 total ) . - Serum lipid profile , glucose insulin measurement baseline , intermediate end intervention . - Anthropometric measurement ( weight , body mass index , waist circumference , body fat percentage ) every month . - A baseline measurement inflammatory cytokine serum every three month ( 5 total ) . - Serum PTH calcium measure baseline end intervention At end intervention , patient control group receive vitamin D supplementation 5 000 IU per day whole year , receive benefit intervention group . Definitions : Heart failure define patient ventricular ejection fraction le 40 percent , serum B natriuretic peptide &gt; 300 milligrams/milliliters . Vitamin D deficiency define serum vitamin D level 30 nano-grams per milliliter . According New York Heart Association ( NYHA ) Classification System : - NYHA III define marked limitation physical activity - NYHA IV define symptom occur even rest ; discomfort physical activity . Statistical analysis plan : Comparison p-value measure baseline end intervention do pair t-test mean McNemar test proportion . According central limit theorem big sample size , need evaluate normality variable ; non-parametric rank test Wilcoxon sign wo n't necessary . For comparison independent group , homogeneity variance evaluate use parametric F test variable normal distribution non-parametric Levene test continuous variable abnormal distribution , compare mean t-test . Mann-Whitney test wo n't necessary reason list . For comparison proportion independent group hold hypothesis test base statistic Z-test , Fisher test small sample . The relation variable measure study variable serum vitamin D level , do Pearson 's correlation coefficient multiple linear regression . That regression evaluate parametric non-parametric test diagnosis autocorrelation , homoscedasticity multicollinearity . Regression analysis do every time vitamin D measurement do ( 5 total ) All result use significance level 0.05 , equivalent possibility type 1 error . Minitab version 16 software ( Minitab Inc , State College , Pennsylvania , USA ) use statistical analysis , Microsoft Excel 2007 ( Microsoft Corp. , Redmond , Washington , USA ) use incorporate input date .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<criteria>1 . Patients heart failure : 1 . Ventricular ejection fraction &lt; 40 % 2 . B natriuretic peptide &gt; 300 milligram per milliliter 3 . Pharmacologic therapy angiotensin convert enzyme inhibitor ( ACEI ) beta blocker ( BB ) 4 . NYHA class III IV 5 . Vitamin D insufficiency ( le 30 ng/ml ) 1 . Subjects without hear failure diagnosis 2 . Subjects ventricular ejection fraction 40 % 3 . Subjects BNP &lt; 300 mg/ml 4 . Subjects n't take ACEI BB 5 . Subjects NYHA class I II 6 . Subjects serum vitamin D â‰¥ 30 ng/ml 7 . Subjects metallic implant ( due magnetic resonance ) 8 . Subjects allergic contrast medium ( gadolinium ) use magnetic resonance 9 . Subjects renal failure due failure eliminate contrast medium Suspension Criteria : 1 . From intervention group : subject stop take supplement take different dosage recommend 80 % time frame 2 . Both group : subject stop attend monthly clinical evaluation cardiologist 3 . Subjects n't show evaluation date give anthropometric measurement laboratory sample take 4 . Subjects n't show final magnetic resonance evaluation 5 . Subjects adverse symptom vitamin D supplementation ; suspect overdose reaction 6 . Subjects allergic reaction magnetic resonance contrast medium ( gadolinium ) magnetic resonance image take</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>heart failure</keyword>
	<keyword>vitamin D deficiency</keyword>
	<keyword>ventricular function</keyword>
	<keyword>cytokine</keyword>
</DOC>